Variant report
Variant | nsv1056021 |
---|---|
Chromosome Location | chr16:75955522-76729765 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2778)
- CpG islands (count:1772)
- Chromatin interactive region (count:78)
- LncRNA region (count:20)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr16:76256042-76256283 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr16:76684292-76684820 | HepG2 | liver: | n/a | n/a |
3 | ARID3A | chr16:76608141-76609300 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr16:76673948-76674099 | K562 | blood: | n/a | n/a |
5 | ARID3A | chr16:76668888-76668938 | K562 | blood: | n/a | n/a |
6 | ARID3A | chr16:76566183-76566513 | HepG2 | liver: | n/a | n/a |
7 | ARID3A | chr16:76687350-76687721 | HepG2 | liver: | n/a | n/a |
8 | ATF1 | chr16:76489943-76489993 | K562 | blood: | n/a | n/a |
9 | ATF1 | chr16:76581402-76581528 | K562 | blood: | n/a | n/a |
10 | ATF1 | chr16:76668805-76669470 | K562 | blood: | n/a | n/a |
11 | ATF1 | chr16:76687134-76687664 | K562 | blood: | n/a | n/a |
12 | ATF1 | chr16:76614425-76614592 | K562 | blood: | n/a | n/a |
13 | ATF1 | chr16:76549644-76549672 | K562 | blood: | n/a | n/a |
14 | ATF2 | chr16:76198817-76199366 | GM12878 | blood: | n/a | n/a |
15 | ATF2 | chr16:76209888-76210374 | GM12878 | blood: | n/a | n/a |
16 | ATF2 | chr16:76209899-76210415 | GM12878 | blood: | n/a | n/a |
17 | ATF3 | chr16:76687346-76687640 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | ATF3 | chr16:76668818-76669064 | K562 | blood: | n/a | n/a |
19 | BACH1 | chr16:76345213-76345518 | H1-hESC | embryonic stem cell: | n/a | chr16:76345351-76345365 |
20 | BACH1 | chr16:76703299-76703491 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | BACH1 | chr16:76345268-76345454 | K562 | blood: | n/a | chr16:76345351-76345365 |
22 | BACH1 | chr16:76228619-76228977 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | BATF | chr16:76610960-76611272 | GM12878 | blood: | n/a | n/a |
24 | BATF | chr16:76210041-76210280 | GM12878 | blood: | n/a | n/a |
25 | BATF | chr16:76610931-76611290 | GM12878 | blood: | n/a | n/a |
26 | BATF | chr16:76337571-76337856 | GM12878 | blood: | n/a | n/a |
27 | BATF | chr16:76617883-76618255 | GM12878 | blood: | n/a | chr16:76618063-76618074 |
28 | BATF | chr16:76332579-76332876 | GM12878 | blood: | n/a | n/a |
29 | BATF | chr16:76617930-76618131 | GM12878 | blood: | n/a | chr16:76618063-76618074 |
30 | BATF | chr16:76332607-76332868 | GM12878 | blood: | n/a | n/a |
31 | BATF | chr16:76337590-76337814 | GM12878 | blood: | n/a | n/a |
32 | BCL11A | chr16:76332629-76332848 | GM12878 | blood: | n/a | n/a |
33 | BCL3 | chr16:76504679-76505105 | GM12878 | blood: | n/a | n/a |
34 | BHLHE40 | chr16:76209948-76210288 | GM12878 | blood: | n/a | n/a |
35 | BHLHE40 | chr16:76199039-76199164 | GM12878 | blood: | n/a | n/a |
36 | BHLHE40 | chr16:76556000-76556061 | K562 | blood: | n/a | n/a |
37 | BHLHE40 | chr16:76704362-76704737 | K562 | blood: | n/a | chr16:76704597-76704606 |
38 | BHLHE40 | chr16:76327637-76327903 | GM12878 | blood: | n/a | n/a |
39 | BHLHE40 | chr16:76329070-76329115 | GM12878 | blood: | n/a | n/a |
40 | BHLHE40 | chr16:76610846-76611310 | GM12878 | blood: | n/a | n/a |
41 | BHLHE40 | chr16:76668642-76669184 | K562 | blood: | n/a | n/a |
42 | BHLHE40 | chr16:76608424-76608923 | HepG2 | liver: | n/a | n/a |
43 | BRCA1 | chr16:76328051-76328056 | GM12878 | blood: | n/a | n/a |
44 | BRCA1 | chr16:76355174-76355243 | Hela-S3 | cervix: | n/a | n/a |
45 | BRCA1 | chr16:76536310-76536336 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | CBX3 | chr16:76371448-76371774 | K562 | blood: | n/a | n/a |
47 | CBX3 | chr16:76668556-76669332 | K562 | blood: | n/a | n/a |
48 | CBX3 | chr16:76668672-76669213 | K562 | blood: | n/a | n/a |
49 | CCNT2 | chr16:76027103-76027303 | K562 | blood: | n/a | n/a |
50 | CCNT2 | chr16:76668739-76669178 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:76668836-76668886 | GM12892 | blood: | n/a |
2 | chr16:76349255-76349305 | GM06990 | blood: | n/a |
3 | chr16:76269043-76269093 | NHBE | bronchial: | n/a |
4 | chr16:76668836-76668886 | GM12892 | blood: | n/a |
5 | chr16:76349255-76349305 | GM06990 | blood: | n/a |
6 | chr16:76269043-76269093 | NHBE | bronchial: | n/a |
7 | chr16:76521159-76521209 | Hepatocyte | liver: | n/a |
8 | chr16:76665665-76665715 | HRCEpiC | kidney: | n/a |
9 | chr16:76343663-76343713 | ProgFib | skin: | n/a |
10 | chr16:76228294-76228344 | HepG2 | liver: | n/a |
11 | chr16:76342620-76342670 | PANC-1 | pancreas: | n/a |
12 | chr16:76311266-76311316 | NT2-D1 | testis: | n/a |
13 | chr16:76256948-76256998 | Jurkat | blood: | n/a |
14 | chr16:76521159-76521209 | HEEpiC | esophagus: | n/a |
15 | chr16:76228294-76228344 | HPAEpiC | pulmonary alveolar: | n/a |
16 | chr16:76521159-76521209 | SAEC | small airway: | n/a |
17 | chr16:76670197-76670247 | PFSK-1 | brain: | n/a |
18 | chr16:76256948-76256998 | Hepatocyte | liver: | n/a |
19 | chr16:76343663-76343713 | AG10803 | skin: | n/a |
20 | chr16:76311050-76311100 | GM12878 | blood: | n/a |
21 | chr16:76309968-76310018 | SAEC | small airway: | n/a |
22 | chr16:76343663-76343713 | NHBE | bronchial: | n/a |
23 | chr16:76342377-76342427 | LNCaP | prostate: | n/a |
24 | chr16:76272351-76272401 | HNPCEpiC | eye: | n/a |
25 | chr16:76343868-76343918 | LNCaP | prostate: | n/a |
26 | chr16:76269184-76269234 | GM06990 | blood: | n/a |
27 | chr16:76272351-76272401 | ECC-1 | luminal epithelium: | n/a |
28 | chr16:76668836-76668886 | PFSK-1 | brain: | n/a |
29 | chr16:76268785-76268835 | T-47D | breast: | n/a |
30 | chr16:76665665-76665715 | NT2-D1 | testis: | n/a |
31 | chr16:76309968-76310018 | SK-N-MC | brain: | n/a |
32 | chr16:76521159-76521209 | MCF10A-Er-Src | breast: | n/a |
33 | chr16:76665665-76665715 | HIPEpiC | eye: | n/a |
34 | chr16:76521159-76521209 | HAEpiC | amniotic membrane: | n/a |
35 | chr16:76311050-76311100 | IMR90 | lung: | fetal |
36 | chr16:76269043-76269093 | HCPEpiC | choroid plexus: | n/a |
37 | chr16:76665665-76665715 | HCPEpiC | choroid plexus: | n/a |
38 | chr16:76311266-76311316 | HL-60 | blood: | n/a |
39 | chr16:76269192-76269242 | PrEC | prostate: | n/a |
40 | chr16:76228294-76228344 | H1-hESC | embryonic stem cell: | embryo |
41 | chr16:76666860-76666910 | HCPEpiC | choroid plexus: | n/a |
42 | chr16:76269192-76269242 | ovcar-3 | ovarian: | n/a |
43 | chr16:76349255-76349305 | HCT-116 | colon: | n/a |
44 | chr16:76670197-76670247 | HEEpiC | esophagus: | n/a |
45 | chr16:76343663-76343713 | HRCEpiC | kidney: | n/a |
46 | chr16:76269043-76269093 | SKMC | muscle: | n/a |
47 | chr16:76269409-76269459 | HEK293 | kidney: | embryo |
48 | chr16:76665665-76665715 | ECC-1 | luminal epithelium: | n/a |
49 | chr16:76228294-76228344 | AG09309 | skin: | n/a |
50 | chr16:76256948-76256998 | HCT-116 | colon: | n/a |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:76337650..76339476-chr16:76348712..76351275,2 | MCF-7 | breast: | |
2 | chr16:75963255..75965166-chr16:75978260..75980431,2 | K562 | blood: | |
3 | chr16:76373071..76375700-chr16:76381006..76383022,2 | MCF-7 | breast: | |
4 | chr16:76703589..76705752-chr16:76708591..76711050,2 | MCF-7 | breast: | |
5 | chr16:76701550..76704283-chr16:76707898..76709517,2 | K562 | blood: | |
6 | chr16:76264260..76266317-chr16:76268267..76270250,2 | MCF-7 | breast: | |
7 | chr16:76319924..76320753-chr16:76686923..76687617,2 | MCF-7 | breast: | |
8 | chr16:76679307..76681357-chr16:76683795..76685911,2 | MCF-7 | breast: | |
9 | chr16:76607256..76609840-chr16:76614807..76617382,2 | K562 | blood: | |
10 | chr16:76312786..76313346-chr16:77205382..77206025,2 | MCF-7 | breast: | |
11 | chr16:76699516..76700310-chr16:77203606..77204151,2 | MCF-7 | breast: | |
12 | chr16:76560975..76563666-chr16:76569503..76571277,2 | K562 | blood: | |
13 | chr16:76109470..76111074-chr16:76115250..76116774,2 | MCF-7 | breast: | |
14 | chr16:75977745..75979693-chr16:75980372..75982208,2 | MCF-7 | breast: | |
15 | chr16:75834944..75835823-chr16:76687371..76688062,3 | MCF-7 | breast: | |
16 | chr16:76665227..76667688-chr16:76668445..76671290,2 | K562 | blood: | |
17 | chr16:76703589..76705752-chr16:76708591..76711050,2 | MCF-7 | breast: | |
18 | chr16:76687235..76688893-chr16:76692839..76694713,2 | K562 | blood: | |
19 | chr16:76150031..76151626-chr16:76156509..76159199,2 | MCF-7 | breast: | |
20 | chr16:76534271..76535887-chr16:76537682..76540215,2 | MCF-7 | breast: | |
21 | chr16:76527293..76528859-chr16:76529180..76530762,2 | MCF-7 | breast: | |
22 | chr16:76472874..76474659-chr16:76475007..76477052,2 | K562 | blood: | |
23 | chr16:76636023..76638622-chr16:76652291..76654068,2 | K562 | blood: | |
24 | chr16:76679307..76681357-chr16:76683795..76685911,2 | MCF-7 | breast: | |
25 | chr16:76312365..76313607-chr16:76673596..76674287,4 | MCF-7 | breast: | |
26 | chr16:76272213..76274617-chr16:76275881..76278722,3 | MCF-7 | breast: | |
27 | chr16:75963255..75965166-chr16:75978260..75980431,2 | K562 | blood: | |
28 | chr16:76421818..76424813-chr16:76424956..76427110,2 | MCF-7 | breast: | |
29 | chr16:76312246..76313469-chr16:76687103..76688657,6 | MCF-7 | breast: | |
30 | chr16:75962160..75963903-chr16:75968199..75970527,2 | K562 | blood: | |
31 | chr16:76152673..76155052-chr16:76163507..76166139,2 | K562 | blood: | |
32 | chr16:76150031..76151626-chr16:76156509..76159199,2 | MCF-7 | breast: | |
33 | chr16:76699506..76700441-chr16:77205329..77206242,3 | MCF-7 | breast: | |
34 | chr16:76230231..76230851-chr2:70141294..70141952,2 | Hela-S3 | cervix: | |
35 | chr16:76584372..76585914-chr16:76586080..76587632,2 | MCF-7 | breast: | |
36 | chr16:76527293..76528859-chr16:76529180..76530762,2 | MCF-7 | breast: | |
37 | chr16:76607256..76609840-chr16:76614807..76617382,2 | K562 | blood: | |
38 | chr10:3005128..3007874-chr16:76409893..76412241,2 | MCF-7 | breast: | |
39 | chr16:76687235..76688893-chr16:76692839..76694713,2 | K562 | blood: | |
40 | chr16:75967179..75969484-chr17:4845937..4847850,2 | MCF-7 | breast: | |
41 | chr16:76519348..76521301-chr16:76524212..76526573,2 | K562 | blood: | |
42 | chr16:76560975..76563666-chr16:76569503..76571277,2 | K562 | blood: | |
43 | chr16:76109470..76111074-chr16:76115250..76116774,2 | MCF-7 | breast: | |
44 | chr16:76319924..76320753-chr16:76686923..76687617,2 | MCF-7 | breast: | |
45 | chr16:76377031..76378891-chr17:57920053..57922098,2 | MCF-7 | breast: | |
46 | chr16:76472874..76474659-chr16:76475007..76477052,2 | K562 | blood: | |
47 | chr16:76167106..76169562-chr16:76172402..76175397,2 | MCF-7 | breast: | |
48 | chr16:75977745..75979693-chr16:75980372..75982208,2 | MCF-7 | breast: | |
49 | chr16:76312246..76313469-chr16:76687103..76688657,6 | MCF-7 | breast: | |
50 | chr16:76076451..76078848-chr2:55275762..55278542,2 | MCF-7 | breast: |
(count:20 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC025287.1-2 | chr16:76141181-76141401 | ENSG00000260223.1 |
2 | lnc-RP11-58C22.1.1-1 | chr16:76669394-76669520 | ENSG00000250514 |
3 | lnc-AC025287.1-3 | chr16:76296129-76296234 | NONHSAT143776 |
4 | lnc-RP11-58C22.1.1-1 | chr16:76690565-76692375 | ENSG00000250514 |
5 | lnc-AC025287.1-3 | chr16:76262283-76262757 | ENSG00000260983.1 |
6 | lnc-RP11-58C22.1.1-1 | chr16:76689454-76689561 | ENSG00000250514 |
7 | lnc-AC025287.1-2 | chr16:76181458-76181704 | ENSG00000260223.1 |
8 | lnc-AC025287.1-3 | chr16:76296129-76296263 | ENSG00000260983.1 |
9 | lnc-AC025287.1-2 | chr16:76170020-76170263 | ENSG00000260223.1 |
10 | lnc-RP11-58C22.1.1-1 | chr16:76668895-76669046 | ENSG00000250514 |
11 | lnc-AC025287.1-3 | chr16:76268585-76269326 | NONHSAT143776 |
12 | lnc-AC025287.1-3 | chr16:76265215-76265343 | ENSG00000260983.1 |
13 | lnc-AC025287.1-2 | chr16:76142134-76142240 | ENSG00000260223.1 |
14 | lnc-AC025287.1-2 | chr16:76181453-76181621 | NONHSAT143772 |
15 | lnc-AC025287.1-2 | chr16:76181454-76181621 | XLOC_012013 |
16 | lnc-AC025287.1-2 | chr16:76169537-76169877 | NONHSAT143772 |
17 | lnc-AC025287.1-3 | chr16:76268953-76269521 | NONHSAT143777 |
18 | lnc-AC025287.1-2 | chr16:76181458-76181677 | ENSG00000260223.1 |
19 | lnc-AC025287.1-2 | chr16:76174260-76174301 | ENSG00000260223.1 |
20 | lnc-AC025287.1-2 | chr16:76169538-76169877 | XLOC_012013 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260223 | TF binding region |
ENSG00000260983 | TF binding region |
ENSG00000264645 | TF binding region |
ENSG00000261833 | TF binding region |
ENSG00000252022 | TF binding region |
RPL18P13 | TF binding region |
ENSG00000250514 | TF binding region |
CNTNAP4 | TF binding region |
RN7SKP233 | TF binding region |
ENSG00000260223 | CpG island |
ENSG00000260983 | CpG island |
ENSG00000264645 | CpG island |
ENSG00000261833 | CpG island |
ENSG00000252022 | CpG island |
RPL18P13 | CpG island |
ENSG00000250514 | CpG island |
CNTNAP4 | CpG island |
RN7SKP233 | CpG island |
ENSG00000152910 | chromatin interactions |
ENSG00000264645 | chromatin interactions |
ENSG00000108523 | chromatin interactions |
ENSG00000261833 | chromatin interactions |
ENSG00000260983 | chromatin interactions |
ENSG00000158373 | chromatin interactions |
ENSG00000115310 | chromatin interactions |
ENSG00000168298 | chromatin interactions |
ENSG00000250514 | chromatin interactions |
ENSG00000244485 | chromatin interactions |
CDV3 | miRNA target sites |
DDX3Y | miRNA target sites |
SPRYD3 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576044187 | chr16:75955528-75955529 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537247374 | chr16:75955580-75955581 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544900880 | chr16:75955660-75955661 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561538081 | chr16:75955685-75955686 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545892153 | chr16:75955699-75955700 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115389771 | chr16:75955701-75955702 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145227065 | chr16:75955710-75955711 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560639017 | chr16:75955730-75955731 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532497163 | chr16:75955745-75955746 | Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551586326 | chr16:75955803-75955804 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147604273 | chr16:75955911-75955912 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372511222 | chr16:75955923-75955924 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13334488 | chr16:75955974-75955975 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs550475351 | chr16:75955995-75955996 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567181269 | chr16:75955997-75955998 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536245081 | chr16:75956007-75956008 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142172093 | chr16:75956049-75956050 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76037439 | chr16:75956054-75956055 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs59445759 | chr16:75956055-75956056 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114588976 | chr16:75956119-75956120 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559225153 | chr16:75956120-75956121 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13334859 | chr16:75956128-75956129 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs544784572 | chr16:75956188-75956189 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191286304 | chr16:75956199-75956200 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372836835 | chr16:75956233-75956234 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536272883 | chr16:75956249-75956250 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs57961261 | chr16:75956285-75956286 | Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs540670514 | chr16:75956381-75956382 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545257189 | chr16:75956387-75956388 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375011700 | chr16:75956452-75956453 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150211775 | chr16:75956501-75956502 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367673818 | chr16:75956557-75956558 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368897818 | chr16:75956558-75956559 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183826162 | chr16:75956569-75956570 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138819638 | chr16:75956602-75956603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562607560 | chr16:75956626-75956627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527713273 | chr16:75956660-75956661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550313065 | chr16:75956779-75956780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567267328 | chr16:75956829-75956830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529933774 | chr16:75956836-75956837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550411521 | chr16:75956885-75956886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs117485032 | chr16:75956911-75956912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566324959 | chr16:75956916-75956917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538602709 | chr16:75956918-75956919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372422792 | chr16:75956959-75956960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs17608180 | chr16:75956973-75956974 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs148924691 | chr16:75956983-75956984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538444900 | chr16:75956998-75956999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555198130 | chr16:75957020-75957021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575118152 | chr16:75957044-75957045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 24585490 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Cancer | 20164919 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20581869 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:75954400-75955600 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
2 | chr16:75954400-75958400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr16:75955000-75955800 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
4 | chr16:75955000-75956200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr16:75955200-75955600 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
6 | chr16:75955400-75955600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr16:75955400-75955600 | Enhancers | Ovary | ovary |
8 | chr16:75955400-75956000 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
9 | chr16:75955600-75955800 | Flanking Bivalent TSS/Enh | iPS-20b Cell Line | embryonic stem cell |
10 | chr16:75955600-75956600 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
11 | chr16:75955800-75956200 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
12 | chr16:75956200-75956400 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
13 | chr16:75956200-75956400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
14 | chr16:75958400-75958800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr16:75958800-75961400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr16:75961400-75961600 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
17 | chr16:75961400-75961600 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
18 | chr16:75961400-75961800 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
19 | chr16:75961400-75962000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
20 | chr16:75961400-75963200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr16:75961600-75961800 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
22 | chr16:75961600-75961800 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
23 | chr16:75961600-75961800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
24 | chr16:75961800-75963200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
25 | chr16:75962000-75962200 | Bivalent Enhancer | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
26 | chr16:75962000-75962200 | Enhancers | HMEC | breast |
27 | chr16:75962200-75964400 | Weak transcription | HMEC | breast |
28 | chr16:75963000-75963200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
29 | chr16:75963200-75964200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
30 | chr16:75963200-75964400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
31 | chr16:75963200-75964400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
32 | chr16:75964200-75964600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
33 | chr16:75964200-75965600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
34 | chr16:75964400-75965600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
35 | chr16:75964400-75965600 | Enhancers | HMEC | breast |
36 | chr16:75964400-75965800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
37 | chr16:75965200-75965400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
38 | chr16:75972000-75973600 | Enhancers | HMEC | breast |
39 | chr16:75972400-75972800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
40 | chr16:75972600-75973200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
41 | chr16:75972800-75973200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
42 | chr16:75972800-75973400 | Enhancers | Brain Cingulate Gyrus | brain |
43 | chr16:75972800-75973600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
44 | chr16:75973000-75973200 | Enhancers | Brain Inferior Temporal Lobe | brain |
45 | chr16:75973200-75978800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
46 | chr16:75973200-75991800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
47 | chr16:75973400-75975000 | Weak transcription | Brain Cingulate Gyrus | brain |
48 | chr16:75974400-75974600 | Enhancers | Fetal Intestine Large | intestine |
49 | chr16:75974800-75975800 | Weak transcription | Fetal Intestine Large | intestine |
50 | chr16:75975000-75975600 | Enhancers | Brain Anterior Caudate | brain |